SAN DIEGO and BETHESDA,
Md., July 1, 2014 /PRNewswire/
-- Shareholder rights law firm Robbins Arroyo LLP is
investigating whether certain officers and directors of Northwest
Biotherapeutics, Inc. (NYSE: NWBO) breached their fiduciary duties
to shareholders. Northwest Bio is a development
stage biotechnology company that develops immunotherapy products to
treat cancers.
View the investigation on the law firm's Shareholder
Rights Blog:
www.robbinsarroyo.com/shareholders-rights-blog/northwest-biotherapeutics-inc
Northwest Bio Shares Drop After Company Violates
Accepted Practice by Releasing Incomplete Research
Data
On June 19, 2014, an article
published on TheStreet.com reported that the MD Anderson Cancer
Center criticized Northwest Bio for their promotional and
unjustified claims regarding results in an ongoing clinical trial
of the cancer vaccine known as DCVax-Direct. According to the
article, Northwest Bio has issued five press releases and held one
press conference since May disclosing preliminary, unconfirmed
results from individual cancer patients who have enrolled in the
DCVax-Direct phase I/II clinical trials. According to the report,
investigators at MD Anderson, one of several sites conducting the
study, have not yet been able to analyze data collected because
patients are still being enrolled and treated in the study.
Following this announcement shares dropped
nearly 20% from $8.97 to close at
$7.18.
Northwest Bio Shareholders Have Legal Options
Robbins Arroyo LLP highlights that Northwest Bio
shareholders have the option to pursue a shareholder litigation
demand or shareholder derivative action through which shareholders
aim to hold insider wrongdoers accountable for their actions,
prevent future misconduct, and bring long-term value back to the
company. Concerned shareholders who would like more
information about their rights and potential remedies can contact
attorney Darnell R. Donahue at
(800) 350-6003,
DDonahue@robbinsarroyo.com, or via the shareholder
information form on the firm's website.
Robbins Arroyo LLP is a nationally recognized leader in
shareholder rights law. The firm represents
individual and institutional investors in shareholder derivative
and securities class action lawsuits, and has helped its clients
realize more than $1 billion of value
for themselves and the companies in which they have
invested.
Attorney Advertising. Past results do not
guarantee a similar outcome.
Contact:
Darnell R. Donahue
Robbins Arroyo LLP
DDonahue@robbinsarroyo.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsarroyo.com
Logo -
http://photos.prnewswire.com/prnh/20130103/MM36754LOGO
SOURCE Robbins Arroyo LLP